WUGEN Inc
BioTech/Drugs - St. Louis, MO, US
WUGEN Inc Senior Management
Ayman Kabakibi
Chief Operating Officer, Executive Vice President of Research & Development
Ayman Kabakibi
Chief Operating Officer, Executive Vice President of Research & Development
WUGEN Inc Details
Wugen is a clinical stage immuno-oncology cell therapy company, developing off-the-shelf NK and CAR-T cell therapies for the treatment of both solid tumor and heme malignancies.Our lead program, WU-NK-101 is being tested in Phase 1b clinical trials. As the first product derived from our memory NK cell therapy platform, WU-NK-101 has shown robust efficacy (and safety) in AML patients.
Website:
wugen.com
Employees:
50 - 99
HQ:
N/A
Location:
St. Louis, MO, US
Revenue:
5 - 10 Million
WUGEN Inc Technologies
Email Providers
Outlook
Domain Name Services
Route 53
Hosted Forms
Gravity Forms
SSL Certificates
OpenSSL
Hosting
Amazon AWS
Email Delivery
Amazon SES